Maria Chiara Gelmi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Maria Chiara Gelmi

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Investigative Ophthalmology & Visual Science|February 4, 2021

Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1- Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After ChemotherapyClelia Miracco, Paolo Toti, Maria Chiara Gelmi, et al.

International Journal of Molecular Sciences|May 27, 2023

Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal MelanomaMaria Chiara Gelmi, Robert M Verdijk, Laurien E Houtzagers, et al.

Ophthalmology|May 26, 2025

ReplyMaria Chiara Gelmi, Laurien E Houtzagers, Annemijn P A Wierenga, et al.

Ophthalmology|September 8, 2024

Survival in Patients with Uveal Melanoma Is Linked to Genetic Variation at HERC2 Single Nucleotide Polymorphism rs12913832Maria Chiara Gelmi, Laurien E Houtzagers, Annemijn P A Wierenga, et al.

Cell Death Discovery|June 15, 2023

Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug targetArwin Groenewoud, Jie Yin, Maria Chiara Gelmi, et al.

Mediators of Inflammation|May 16, 2020

New Potential Weapons for Refractory Scleritis in the Era of Targeted TherapyClaudia Fabiani, Jurgen Sota, Maite Sainz-de-la-Maza, et al.

Investigative Ophthalmology & Visual Science|January 25, 2024

Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma ModelSen Ma, Ruben V Huis In't Veld, Yang Hao, et al.

Ophthalmology Science|May 16, 2023

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1Maria Chiara Gelmi, Annemijn P A Wierenga, Wilma G M Kroes, et al.

Investigative Ophthalmology & Visual Science|July 23, 2024

Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation StatusMaria Chiara Gelmi, Arnoud H de Ru, Peter A van Veelen, et al.

Ophthalmology|November 15, 2021

Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris ColorAnnemijn P A Wierenga, Niels J Brouwer, Maria Chiara Gelmi, et al.

Pageof 2

Search research articles

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Investigative Ophthalmology & Visual Science|February 4, 2021

International Journal of Molecular Sciences|May 27, 2023

Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal MelanomaMaria Chiara Gelmi, Robert M Verdijk, Laurien E Houtzagers, et al.

Ophthalmology|May 26, 2025

ReplyMaria Chiara Gelmi, Laurien E Houtzagers, Annemijn P A Wierenga, et al.

Ophthalmology|September 8, 2024

Survival in Patients with Uveal Melanoma Is Linked to Genetic Variation at HERC2 Single Nucleotide Polymorphism rs12913832Maria Chiara Gelmi, Laurien E Houtzagers, Annemijn P A Wierenga, et al.

Cell Death Discovery|June 15, 2023

Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug targetArwin Groenewoud, Jie Yin, Maria Chiara Gelmi, et al.

Mediators of Inflammation|May 16, 2020

New Potential Weapons for Refractory Scleritis in the Era of Targeted TherapyClaudia Fabiani, Jurgen Sota, Maite Sainz-de-la-Maza, et al.

Investigative Ophthalmology & Visual Science|January 25, 2024

Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma ModelSen Ma, Ruben V Huis In't Veld, Yang Hao, et al.

Ophthalmology Science|May 16, 2023

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1Maria Chiara Gelmi, Annemijn P A Wierenga, Wilma G M Kroes, et al.

Investigative Ophthalmology & Visual Science|July 23, 2024

Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation StatusMaria Chiara Gelmi, Arnoud H de Ru, Peter A van Veelen, et al.

Ophthalmology|November 15, 2021

Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris ColorAnnemijn P A Wierenga, Niels J Brouwer, Maria Chiara Gelmi, et al.

Pageof 2